Betulinic acid inhibits non-small cell lung cancer by repolarizing tumor-associated macrophages via mTOR signaling pathway
The abnormal activation of the mammalian target of rapamycin(mTOR)signaling pathway in non-small cell lung cancer(NSCLC)is closely associated with distant metastasis,drug resistance,tumor immune escape,and low overall survival.The present study reported that betulinic acid(BA),a potent inhibitor of mTOR signaling pathway,exhibited an inhibitory activity against NSCLC in vitro and in vivo.CCK-8 and colony formation results demonstrated that BA significantly inhibited the viability and clonogenic ability of H1299,A549,and LLC cells.Additionally,the treatment with BA induced mitochondrion-mediated apoptosis of H1299 and LLC cells.Furthermore,BA inhibited the mobility and invasion of H1299 and LLC cells by down-regulating the expression level of matrix metalloproteinase 2(MMP2)and impairing epithelial-mesenchymal transition.The results demonstrated that the inhibition of mTOR signaling pathway by BA decreased the proportion of M2 phenotype(CD206 positive)cells in total macrophages.Furthermore,a mouse model of subcutaneous tumor was established with LLC cells to evaluate the anti-tumor efficiency of BA in vivo.The results re-vealed that the administration of BA dramatically retarded the tumor growth and inhibited the proliferation of tumor cells.More impor-tantly,BA increased the ratio of M1/M2 macrophages in the tumor tissue,which implied the enhancement of anti-tumor immunity.In conclusion,BA demonstrated the inhibitory effect on NSCLC by repolarizing tumor-associated macrophages via the mTOR signaling pathway.
NETL
NSTL
万方数据
